Max Kepler Suspended 80 Games for PED Use

Why this matters: This suspension significantly impacts Kepler's career and earning potential. Teams will be hesitant to sign a player who will miss half the season and is ineligible for the playoffs. It also highlights MLB's ongoing efforts to combat performance-enhancing drug use.

Max Kepler's suspension adds another layer of complexity to his free agency. After a disappointing season with the Phillies, where he expressed frustration over his role, Kepler was already facing a challenging market. The suspension further diminishes his value, as teams must now weigh the cost of signing a player who will be unavailable for a significant portion of the season.

Kepler's career with the Minnesota Twins showed promise, accumulating 20.6 Baseball-Reference wins above replacement and hitting 161 home runs. However, his recent performance decline and the PED suspension raise serious questions about his future in MLB.

Other outfielders like Harrison Bader, Miguel Andujar, and Austin Hays may see increased interest due to Kepler's situation. Teams seeking outfield help may opt for players who can contribute immediately without the baggage of a suspension.

Epitrenbolone, a performance-enhancing substance.

80 games.

When Kepler signs with a team.

No, he is ineligible as part of MLB's drug program.

What impact do you think this suspension will have on Max Kepler's career? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!